Open AccessBASAL CELL CARCINOMA WITH LYMPH NODE METASTASIS A CASE REPORT AND REVIEW OF LITERATURE
Author(s) -
O. Elatiqi,
AUTHOR_ID,
Moulay Driss Elamrani,
Yassine Benchamkha,
AUTHOR_ID,
AUTHOR_ID
Publication year - 2022
Publication title -
international journal of advanced research
Language(s) - English
Resource type - Journals
ISSN - 2320-5407
DOI - 10.21474/ijar01/14099
Subject(s) - basal cell carcinoma , medicine , vismodegib , merkel cell carcinoma , radiation therapy , lymph node , basal cell , skin cancer , chemotherapy , metastasis , lymphatic system , cancer , carcinoma , oncology , pathology , radiology
Basal cell carcinoma (BCC) is the most common skin cancer. Metastatic BCC is rare (0,0028% to 0,5%), with a very poor prognosis, survival rates of 3 years, in cases of locoregional lymphatic metastases,is estimated at 8 months. For this form of basal cell carcinoma,treatment is based on surgery and radiotherapy, chemotherapy bye Platinum-based or the inhibitors of the Hedgehog vismodegibcan be used for non-operative patients. We report a case of a 41 years old male man who suffered from BCC on his right cheek with lymph node metastases.